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Abstract
Background The neovascular form of age-related macular
degeneration (AMD) manifested with choroidal neovascu-
larization (CNV) is one of the leading causes of rapid and
irreversible visual loss. Recent reports suggest that bone
marrow-derived stem/progenitor cells (SPCs) play a crucial
role in the development and progression of the disease. The
purpose of this study was to investigate whether or not
undifferentiated non-haematopoietic stem cells, including
those capable of differentiating into neural phenotypes, play
a role in the pathological state of CNV formation.
Methods Peripheral blood samples were collected from 46
patients diagnosed with CNV and from 46 controls. The
CXCR4
+Lin
-CD45
- stem cells were counted and analysed
by flow cytometry. Using qRT-PCR and immunocyto-
fluorescence, the expression of early neural and glial
cell markers (β-III-tubulin, nestin, and glial fibrillary
acidic protein) in the sorted cells was analysed, and
correlated with plasma concentrations of stromal cell-derived
factor 1 (SDF-1) (enzyme-linked immunosorbent assay),
which is a pivotal chemokine that regulates the trafficking of
SPCs.
Results We found that the number of circulating
CXCR4
+Lin
-CD45
- cells did not differ in patients with
active CNV as compared to the controls. However, we
noticed significant intracellular overexpression of β-III-
tubulin inthe cells derived fromAMD patients. Moreover, we
observed significantly lower SDF-1 plasma levels in neo-
vascular AMD patients compared to healthy individuals.
Conclusions Our findings suggest that neural progenitor
cells, together with low SDF-1 concentrations, may play a
considerable role in the process of AMD progression.
Further investigations aimed at the precise elucidation of
these issues may help with the future development of
effective prevention against, and the treatment of, this
disease.
Keywords Age-related macular degeneration.Choroidal
neovascularisation.Tissue-committed stem cells
Introduction
Age-related macular degeneration (AMD) is one of the
leading causes of irreversible visual loss in people 65 years
of age and older in the western world [1]. It represents a
degenerative and progressive condition involving the retinal
pigment epithelium (RPE), Bruch’s membrane and the
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characterized by the invasion of new pathological vessels
under the macula (choroidal neovascularization, CNV), and it
isassociatedwitharapidandseverelossofvision[2]. Despite
the fact that our understanding of molecular events presaging
AMD has grown in the last decade, the pathogenesis of
AMD is still not entirely clear [3].
Recent research strongly suggests that bone marrow-
derived stem/progenitor cells may play an important role in
thedevelopmentandprogressionofthedisease[4]. During the
last decade, a growing body of evidence has suggested that
bone marrow contains undifferentiated non-haematopoietic
tissue-committed stem cells (TCSCs), which include cells
capable of differentiating into neural phenotypes, for example
neurons, astroglia and oligodendroglia. These stem/progenitor
cells (SPCs) circulate in the peripheral blood, therefore
maintaining a pool in distant tissues and playing a role in
tissue regeneration. The trafficking of these cells is regulated
by various chemokines and their receptors, including the
pivotal stromal cell-derived factor 1 (SDF-1)-CXCR4 axis
[5]. The secretion of SDF-1 increases during tissue damage,
such as during ischaemia, toxic damage or total body
irradiation, and the SDF-1 secreted during local tissue injury
may play a role in chemoattracting the TCSCs necessary for
organ/tissue renewal [6].
However, the precise subpopulation of cells that is the
source of neural and glial TCSCs remains unidentified. A
substantial level of diversity has been reported with regard
to the identity of these cells. Most studies have indicated
heterogeneous or poorly characterized populations of cells
[7]. Although some of the cell candidates were defined
according to their classification as non-haematopoietic stem
cells, there are no standardized criteria with which to
determine their phenotype. To date, it has been common to
isolate and characterize non-HSCs stem cells by their lack
of CD45 expression and their lineage antigens [8].
Up until now, no study has actually examined the
concentrations of circulating TCSCs in the peripheral blood
of AMD patients. In order to investigate whether or not SPCs
play a role in the pathological state of CNV formation, we
examined circulating CXCR4
+Lin
-CD45
- cells from patients
with exudative AMD and healthy controls, and analysed the
expressionofearlyneuralandglialcellmarkers.Additionally,
we correlated our findings with SDF-1 plasma levels and
clinical data, including any accompanying vascular disorders.
We found that the number of circulating CXCR4
+Lin
-CD45
-
cells did not differ in patients with active CNV. However, the
cells derived from AMD patients significantly overexpressed
β-III-tubulin. To the best of our knowledge, this is the first
study on circulating non-haematopoietic TCSCs in individuals
with AMD.
Materials and methods
Characteristics and selection of the study groups
Participants were recruited from the outpatient population
of the Department of Ophthalmology of Pomeranian
Medical University in Szczecin, Poland. All of the enrolled
subjects underwent a complete ophthalmic examination, i.e.,
visual acuity and intraocular pressure measurements and
dilated fundus examination using slit-lamp biomicroscopy.
Forty-six subjects with a clinical diagnosis of exudative
AMD, with newly diagnosed CNV characterized by serous
or haemorrhagic retinal pigment epithelium detachment,
subretinal neovascular membrane, subretinal haemorrhage,
or fibrous scar, were included in the study. The severity of
AMD, based on the size and laterality of the lesions, was
characterized by fluorescein angiography and by optical
coherence tomography imaging. Patients who had previously
been submitted for laser or intravitreal treatment were
excluded from the study. In the case of different stages of the
disease being diagnosed in each eye, the subject was
categorized according to the severity of changes in the
worse eye. Forty-six age- and sex-matched volunteers
without AMD (defined as the absence of drusen, pigmentary
abnormalities or neovascularization) were enrolled as the
control group.
Data regarding medical history and smoking status were
collected, with special attention being paid to arterial
hypertension and pre-existing cardiovascular and cerebro-
vascular conditions.
Exclusion criteria included significant chronic sys-
temic conditions, for example collagen or neoplastic
disease, diabetes mellitus, renal failure, hepatic dysfunction
and any evidence of retinal disease, with the exception
of AMD (in AMD groups), i.e., glaucoma, intraocular
inflammatory diseases, and recent (within 3 months) ocular
surgery.
The study adhered to the tenets of the Declaration of
Helsinki, and approval was obtained from the Local
Research Ethics Committee. Moreover, each patient gave
written informed consent for his or her involvement.
Sample collection
Venous blood samples (~7.5 ml) collected in EDTA tubes
were centrifuged (2000 rpm, 4°C, 10 min) and the plasma
was stored at −20°C to −80°C until assayed. The red blood
cells were lysed using BD Pharm Lyse lysing buffer (BD
Biosciencies, San Jose, CA, USA) for 15 min at room
temperature to isolate peripheral blood nuclear cells
(PBNCs).
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Two million (2×10
6) PBNCs were stained with monoclonal
antibodies for lineage markers (CD56, CD235a, CD3,
CD66b, CD24, CD19, CD14, CD16, CD2) conjugated
with fluorescein isothiocyanate (FITC), CD45 conjugated
with phycoerythrin (PE), and CXCR4 conjugated with
allophycocyanin (APC) (BD Biosciences, San Jose, CA,
USA) (Fig. 2). In the control experiment the cells were
stained with secondary isotypic antibodies: IgM, IgG1,
IgG2a-FITC, IgG1-PE and IgG1-APC for the lineage
antigens CD45 and CXCR4. The samples were incubated
with antibodies at room temperature for 30 min, then
washed and suspended in 1% formaldehyde. Flow analysis
was performed on an LSR II instrument (BD Biosciences,
San Jose, CA, USA). At least 10
5 events were acquired and
analysed using Cell Quest software (BD Biosciences, San
Jose, CA, USA). The number of cells in each population
was expressed as a percentage of the total events.
Isolation and immunofluorescence of peripheral
blood-derived SPCs
The population of CXCR4
+Lin
-CD45
- cells was sorted by
multiparameter, live sterile cell sorting (BD FACSAriaIIu
Cell-Sorting System, BD Biosciences, San Jose, CA, USA).
Cell staining for all of the antigens was performed as
previously described. The sorted cells were permeabilized
(0.1% Triton X-100, 10 min) and stained for β-III-tubulin
(OriGene Technologies, Rockville, MD, USA), nestin
(Novus Biologicals, Littleton, CO, USA) and glial fibrillary
acidic protein (GFAP) (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) antigens with anti-human monoclonal
antibodies for 1 h atroomtemperature followedby incubation
with a secondary antibody conjugated to FITC (Sigma, St.
Louis, MO, USA). The cells were subsequently fixed (3.7%
paraformaldehyde) and the nuclei were stained with DAPI
(Invitrogen, Paisley, UK). Isotype control antibody (APC-
conjugated) staining was performed analogously to check if
anyunspecificantibodybindingoccured.Forthesamereason,
the cells were stained solely with anti-rabbit secondary
antibody (FITC-conjugated), omitting the primary antibody.
TheBDBiosciencesPathway855bioimager(BDBiosciences,
Rockville, MD, USA) was used for fluorescence images.
Real-time reverse transcriptase-polymerase chain reaction
(qRT-PCR)
Total mRNA was isolated from PBNCs (2×10
6) using an
RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany). The
RNAwas reverse-transcribedwithMoloneymurine leukaemia
virus reverse transcriptase and oligo dt primers (Fermentas
International Inc., Burlington, Canada). Quantitative assess-
ment of the mRNA levels for early neural and glial cell
markers was performed by real-time RT-PCR on a Bio-Rad
CFX96 Real-Time PCR Detection System (Bio-Rad Inc.,
Philadelphia, PA, USA). A 25-μl reaction mixture contained
12.5 μlo fi QS Y B E RG r e e nS u p e r m i xr e a g e n t ,1 0n go f
cDNA template, and one of each of the primer pairs: 5′-ACA
CCT GTG CCA GCC TTT CTT-3′ (forward) and 5′-TGA
ACA CTC TAG ACC CAC CG-3′(reverse) primers for nestin;
5′-GTG GGC AGG TGG GAG CTT GA-3′ (forward) and 5′-
CTG GGG CGG CCT GGTATG AC-3′ (reverse) primers for
GFAP;5′-CGAGTCGCCCACGTAGTTG-3′(forward)and
5′-TTC TGG GAA GTC ATC AGT GAT-3′ (reverse) primers
for β-III-tubulin and 5’-AAT GCG GCATCT TCA AAC CT-
3’ (forward) and 5’-TGA CTT TGT CAC AGC CCA AGA
TA-3’ (reverse) primers for beta-2 microglobulin (BMG),
designed using Primer Express software (Applied Biosystems,
Foster City, CA, USA). The real-time cycling conditions were:
1 cycle at 95°C for 10 min, followed by 40 cycles at 95°C for
15 s, 60°C for 1 min, and 72°C for 15 s. Relative quantification
of mRNA expression was performed using the comparative Ct
method. The relative quantization value of the target,
normalized to an endogenous control BMG (housekeeping)
geneandrelativetoa calibrator,was expressedas2
ΔCt, where
ΔCt=[Ct of the endogenous control gene (BMG)] - [Ct of
the target gene].
ELISA
Plasma concentrations of stromal derived factor-1 alpha
(SDF-1α) were measured using commercially available
enzyme-linked immunosorbent assay (ELISA) Quantikine
kits (R&D Systems, Minneapolis, MN, USA) according to
the manufacturer’s protocol. Calibration was performed
with recombinant human SDF-1α in the concentration
range 156 to 10,000 pg/ml. Absorbance was read at 450 nm
using an ELX 808IU automated Microplate Reader (Bio-Tek
Instruments Inc). The results were analysed using a
quadratic or 4PL algorithm curve fit. The limit of detection
was 18 pg/ml. Intra-assay precision (CV%) was 3.4–3.9%,
while inter-assay precision was 8.2–13.4%.
Statistics
Quantitative variables were compared between groups with
the Mann–Whitney test. Fisher’s exact test was used for
nominal variables. Correlations between quantitative vari-
ables were measured with Spearman’s rank correlation
coefficient. Multivariate analyses were performed using
General Linear Model (GLM); variables with non-normal
Graefes Arch Clin Exp Ophthalmol (2011) 249:1785–1794 1787distributions (Shapiro–Wilk test) were transformed loga-
rithmically for this analysis. Results with p<0.05 were
considered statistically significant.
Results
Characteristics of study subjects
The characteristics of the patients and controls are summa-
rizedinTable1. The AMD and control groups were matched
for age, gender, and selected well-known AMD risk factors,
including hypertension, history of ischaemic heart disease
and stroke. The rate of past smokers was slightly higher in
the AMD group than in the control group (p=0.054).
However, no difference was found between current smokers
in the AMD and control groups. Moreover, in the AMD
group, a positive association between patient age and lesion
diameter, as well as patient age andbilateral CNV, was noted.
This means that patients who manifested bilateral CNVand a
larger diameter of the macular lesion were significantly older
compared to those with unilateral changes (median: 79 vs
72 years; p=0.020) and to those with a smaller CNV area
(median: 76 vs 69 years; p=0.014), respectively.
Enumeration of CXCR4
+Lin
-CD45
- cells in peripheral
blood of AMD patients and controls
Next, we focused on evaluating the number of
CXCR4
+Lin
-CD45
- cells in the peripheral blood (Fig. 1).
We did not observe any significant difference in the number
of cells analysed between AMD and control groups
(median: 0.0059% and 0.0071%, respectively, p=0.51)
The results obtained suggest that age-related macular
degeneration is not an independent factor triggering the
mobilization of SPCs from the bone marrow.
Interestingly, in the control group, we noted a strong
negative correlation between patient age and the number of
cells analysed in peripheral blood (Rs= −0.38, p=0.0096).
This implies that a noticeably larger amount of SPCs was
observed in younger individuals. The results obtained
corroborate the previous observations, indicating that
younger individuals display a higher regenerative potential.
Moreover, in the AMD group, a greater number of
CXCR4
+Lin
-CD45
- cells was observed in males (median:
0.0097% vs 0.0044%, p=0.019).
Since there are available data suggesting that AMD is
associated with underlying systemic vascular disease [9], we
assessed the impact of the abovementioned coincidence on
SPC mobilisation into peripheral blood. We noted that those
patients with concurrent vascular diseases had a significant
reduction in CXCR4
+Lin
–CD45
- cells. In patients with AMD
and concomitant ischaemic heart disease, or history of
stroke, a lower percentage of SPCs analysed in peripheral
blood was found than in those without accompanying
vascular disorders (Table 2). A similar tendency was
observed in the control group. Furthermore, a decrease in
the numbers of CXCR4
+Lin
–CD45
- cells was observed in
hypertensive individuals in the control group. The number of
SPCs analysed in blood seemed to be unaffected either by
the size and laterality of the disease or by the smoking status
of the patients.
The expression of neuroprogenitor and glial cell markers
in SPCs
In order to obtain detailed characteristics of peripheral blood
SPCs, we analysed them for the presence of early neural and
glial cell markers. Accordingly, the CXCR4
+Lin
–CD45
- cell
population sorted from among the PB cells was labelled with
antibodies directed against nestin, GFAP and β-III-tubulin.
Figure 2 shows the results of the microscope analysis of the
Table 1 Clinical characteristics
of the study groups Control group AMD group P value
Number of subjects 46 46 –
Sex (male / female) 13 / 33 23 / 23 0.054
Mean±SD Mean±SD
Patient’s age (years) 72.7±8,3 72.0±8.8 0.88
%%
Bilateral CNV – 30 –
Size of lesion >3000 μm – 54 –
Current smokers 5 11 0.43
Past smokers 40 62 0.054
Hypertension 64 51 0.29
History of ischemic heart disease 33 16 0.086
History of stroke 5 2 1.0
1788 Graefes Arch Clin Exp Ophthalmol (2011) 249:1785–1794isolated cell populations. A clearly evident expression
of the three antigens analysed in the cytoplasm of
CXCR4
+Lin
–CD45
- corroborate the presence of early neural
progenitors in the peripheral blood of AMD patients.
Next, we performed a quantitative analysis of the expres-
sion of the abovementioned markers in PB cells by qRT-PCR
(Table 3). The expression of β-III-tubulin was significantly
higher in the AMD group compared to healthy volunteers
(p=0.0074). The difference remained significant in the
multivariate analysis performed in the General Linear Model
after adjustment for age, gender, smoking status, presence of
ischaemic heart disease and hypertension (ß=+0.29; p=
0.029). However, no differences were observed in the
expression of nestin or GFAP between the AMD and control
groups. This may indicate that the advanced stage of the
disease (i.e., neovascular AMD) is accompanied by the
mobilization of more differentiated neural progenitors with
high β-III-tubulin expression.
Subsequent correlation analysis of the neuroprogenitor and
glial cell markers showed positive correlations between the
expressions of these antigens. In both of the groups
investigated, a positive correlation was observed between
the mRNA expression of GFAP and β-III-tubulin (Rs=+0.33,
p=0.033 in the control group, and Rs=+0.65, p<0.001 in
AMD patients), as well as between nestin and β-III-tubulin
(Rs=+0.35; p=0.048 in the control group, and Rs=+0.56;
p=0.016 in the AMD group). Moreover, such a relationship
was also revealed between the expression of GFAP and
Fig. 1 Strategy for analysing CXCR4
+Lin
–CD45
- stem/progenitor
cells based on their size and antigen profile. a Cell distribution based
on the FSC (forward scatter) and SSC (side scatter) parameters that
describe their size and granularity, respectively. b Analysis of cells
according to their lineage markers and CXCR4 expression. The cells
enclosed in the P2 region were further analysed based on their CD45
antigen expression (c). d Presentation of the percentages of
CXCR4
+Lin
–CD45
-stem cells circulating in the peripheral blood of
AMD patients and the control group. The values are expressed as
percentages of the total peripheral blood nuclear cells. Q1–Q3 —
upper and lower quartiles
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+Lin
-CD45
- stem cells circulating in the peripheral blood of subgroups of AMD patients and controls stratified
according to clinical features
Clinical feature Subgroup Control group AMD group
Median (IQR) P-value Median (IQR) P-value
Gender Female 0.0083 (0.0092) 0.980 0.0044 (0.0058) 0.019
Male 0.0060 (0.0049) 0.0097 (0.0164)
History of ischemic heart disease or stroke Yes 0.0047 (0.0047) 0.088 0.0030 (0.0019) 0.058
No 0.0095 (0.0099) 0.0085 (0.0089)
Current smoking Yes 0.0071 (0.0083) 0.932 0.0091 (0.0470) 0.164
No 0.0066 (0.0045) 0.0047 (0.0095)
Past smoking Yes 0.0060 (0.0053) 0.853 0.0043 (0.0083) 0.294
No 0.0069 (0.0106) 0.0081 (0.0085)
Hypertension Yes 0.0047 (0.0060) 0.0043 (0.0058)
No 0.0106 (0.0107) 0.014 0.0094 (0.0099) 0.217
Bilateral CNV Yes – 0.0088 (0.0098)
No –– 0.0050 (0.0072) 0.225
Size of lesion >3000 μmY e s –– 0.0094 (0.0100) 0.191
No – 0.0044 (0.0059)
Fig. 2 Identification of
CXCR4
+Lin
–CD45
- TCSCs
derived from the peripheral
blood of AMD patients. The
individual images depict the
expression of CXCR4 and β-III-
tubulin (a), GFAP (b) and nestin
(c) antigens in isolated
CXCR4
+Lin
–CD45
-cells. The
nuclei were visualized via DAPI
staining. A pseudocolour was
assigned to each stain as
follows: anti-CXCR4 – red,
anti-nestin, β-III-tubulin and
GFAP – green, nuclei – blue.
The control images (the upper
boxed insets) confirm no unspe-
cific binding of antibodies. The
scale bar shows 5 μm. Repre-
sentative data are shown
1790 Graefes Arch Clin Exp Ophthalmol (2011) 249:1785–1794nestin in the AMD group (Rs=+0.70; p<0.001). Therefore,
this may indicate that the genes/proteins analysed are
basically present in a relatively homogeneous cell population
(Table 4).
Subsequently,weassessedtheeffectofunderlyingvascular
diseases on the expression of nestin, GFAP, and β-III-tubulin
in PB cells. In the AMD patients, we observed a higher
expressionofGFAPinsubgroupswithischaemicheartdisease
or a history of stroke compared to those without these
concomitant diseases (medians: 27.6 vs 9.8; p=0.0013).
Likewise, the expression of β-III-tubulin was also found to
be higher in these patients, although the difference was at
borderline significance (medians: 0.152 for atherosclerotic
individuals vs 0.093 for non-atherosclerotic individuals; p=
0.066). Furthermore, in the control group the expression of
GFAP proved to be noticeably higher in atherosclerotic
individuals (medians: 27.3 vs 10.3; p=0.020). Analogous
associations were revealed regarding hypertension. In the
control group, the expression of GFAP was higher in
hypertensive individuals (medians: 14.6 vs 4.1; p=0.051).
Similarly, in the AMD group, a higher expression of nestin
was observed in patients with hypertension, although the
difference had borderline significance (medians: 14.53 vs
4.42; p=0.064). Expression of the neuroprogenitor and glial
cell markers analysed was unaffected by size or laterality of
CNV, as well as by the smoking status of the patients.
Furthermore, in our study, in order to characterize the
cells more accurately, we evaluated the association between
the number of circulating non-HSCs and the expression of
the markers analysed at the mRNA level. Remarkably, we
noticed a negative correlation between the number of
CXCR4
+Lin
–CD45
- cells in peripheral blood and the
intracellular expression of all of the markers analysed in
AMD patients (Rs=−0.54; p=0.0083 for GFAP; Rs=−0.61;
p=0.0043 forβ-III-tubulin;Rs=−0.67; p=0.0013 for nestin).
This may suggest that the impairment of CXCR4
+Lin
–CD45
-
cell mobilization to the peripheral blood is accompanied by
their relative enrichment in neural and glial cell progenitors.
Plasma SDF-1 levels in AMD patients and controls
The SDF-1 plasma level was found to be evidently lower in
patientswithAMDcomparedtothecontrolgroup(p=0.0031)
(Fig. .3). Multivariate analysis of patients and controls,
adjusted for age, gender and smoking status (past or present),
as well as the presence of ischaemic heart disease and
hypertension, revealed that AMD was an independent factor
associated with lower SDF-1 plasma concentrations (ß=
−0.32; p=0.0012). Moreover, in the control group (but not
the AMD group), we found that the plasma SDF-1 level was
higher in subjects with hypertension (median 2860 vs
2032 pg/ml, p=0.0004) and individuals with ischaemic heart
disease or a history of stroke (median: 3162 vs 2122 pg/ml,
p=0.0005) than in control participants with no history of
Table 3 Expression of nestin, β-III-tubulin, andGFAPatthemRNAlevelinperipheralbloodnuclearcells.Transcriptquantityisexpressedinrelative
units against the β2-microglobulin control gene (2
ΔCt , where Ct represents the threshold cycle difference between the control and target genes)
Parameter Control group AMD group Statistical significance
b
n mean±SD median (IQR)
a n mean±SD median (IQR)
a
GFAP 41 19,8±25,53 11,36 (19,1) 41 25,84±75,07 10,17 (9,47) 0,64
β-III-tubulin 44 0,12±0,25 0,0415 (0,0618) 38 0,67±2,48 0,1019 (0,0663) 0.0074
Nestin 40 23,2±42,19 7,06 (16,76) 45 25,25±67,28 7,71 (13,03) 1.00
a IQR — interquartile range,
b Mann–Whitney U test for comparison of two groups
Table 4 Correlation between the expression of some neuroprogenitor
and glial cell markers in the study groups
Correlated parameters Control group AMD group
Rs
a p
b Rs
a p
b
GFAP and β-III-tubulin +0.33 0.033 +0.65 <0.001
GFAP and nestin +0.29 0.1 +0.7 <0.001
Nestin and β-III-tubulin +0.35 0.048 +0.55 0.016
a Spearman’s rank correlation coefficient;
b statistical significance for
Spearman’s rank correlation coefficient
Fig. 3 Plasma concentrations of SDF-1 in AMD patients and in the
control group. The values are expressed in pg/ml. Q1–Q3 — upper
and lower quartiles
Graefes Arch Clin Exp Ophthalmol (2011) 249:1785–1794 1791these diseases. Additionally, in control individuals, a strong
negative correlation was observed between the number of
CXCR4
+Lin
–CD45
- cells and the SDF-1 plasma level (Rs=
−0.52, p=0.0003). Similarly, we noted a negative correlation
between SDF-1 concentration and the intracellular expres-
sion of β-III-tubulin in AMD patients (Rs=−0.44, p=0.039).
The negative correlation between SDF-1 concentration and
the intracellular expression of nestin in controls had
borderline significance (Rs=−0.30; p=0.10).
Discussion
Age-related macular degeneration is caused by a series of
metabolic and histological changes in the retina and
underlying tissues, which culminate in progressive retinal
atrophy and, in the most severe form, neovascularisation.
Abnormal blood vessel growth begins in the vascular
choroid, which gradually invades the outer retina, and the
accompanying leak of blood and fluid secondarily damage
the photoreceptor cells [2].
Attempts at retinal self-regeneration in the course of
AMD could be considered possible based on reports
indicating the role of bone-marrow-derived SPCs in this
process [10]. Bone marrow is considered to be the richest
reservoir of versatile stem/progenitor cells, maintaining
constant haematopoiesis and supporting the homeostasis
of other tissues. Accumulating evidence indicates that in
addition to haematopoietic stem cells, different types of
non-haematopoietic TCSCs reside in the BM and possess
the potential to differentiate into a variety of mature cells,
including those with neural and retinal characteristics [11–
13]. Apart from cellular differentiation into the target tissue
type, the beneficial effect of SPCs can be achieved via other
ways, e.g., antiapoptotic signalling or paracrine cross-talk.
Furthermore, as reported recently, SPCs are able to
modulate local inflammatory processes [14].
Since early non-HSCs may actually represent diverse cell
populations and cannot be purely defined based on their
phenotype, we focused on the cells expressing CXCR4 (a
receptor for SDF-1 alpha-chemokine) that are lineage-
negative as well as CD45-negative (non-haematopoietic).
The phenotype of the analysed CXCR4
+Lin
–CD45
- cells
corresponds to some extent to very small embryonic-like
SCs (VSEL-SCs) that express pluripotent SC markers, as
recently described in human umbilical cord and peripheral
blood, with a contribution by our research team [15]. The
phenotype of VSEL-SCs is characterized by the expression
of surface CXCR4, CD133, and/or CD34 antigens, as well
as by nuclear embryonic Oct-4 and Nanog markers. In
addition, VSEL-SCs are also lineage- and CD45-negative
[16]. Hence, the population of CXCR4
+Lin
–CD45
- cells that
was analysed contained a “cocktail” of diverse early SPCs
enriched with neural progenitors.
In this study, we performed a quantitative and qualitative
characterization of circulating CXCR4
+Lin
–CD45
- cells in
patients with the neovascular form of AMD. We found no
significant differences between the concentrations of the
cells analysed in the AMD and healthy control groups,
which indicates that the analysed cell population did not
undergo a noticeable mobilization into PB during the
course of AMD. Several studies have shown atherosclerotic
diseases to be a risk factor preceding AMD [17]. Moreover,
there is a great body of evidence that AMD occurs mutually
with vascular disorders or may independently predict stroke
or coronary heart disease [18, 19]. Interestingly, the
circulating CXCR4
+Lin
–CD45
- cell concentration signifi-
cantly decreased in hypertensive patients and in individuals
with a history of cardiovascular disease or stroke. The
diminished CXCR4
+Lin
–CD45
- cell numbers in these
patients might well have resulted from a gradual collapse
of the supply of this cell population during the course of
chronic vascular impairment. In support of this notion,
reduced levels of circulating CXCR4-positive cells have
previously been reported in diabetes and cardiovascular
disease, as well as in cardiac transplant recipients [20–22].
In addition, recently published reports indicated that the
number of circulating SPCs steadily decreases with the
increasing age of individuals [23]. Our findings correspond
with the abovementioned observations, as we revealed a
strong negative correlation between PB CXCR4
+Lin
–CD45
-
cell concentrations and the patient’s age within the healthy
control group. However, the possibility that the reduced
concentrations of these analysed cells in individuals with
concomitant hypertension and/or atherosclerosis could
be attributed to the recruitment of these cells from the
PB and reattachment to the site of injury (i.e., the
ischaemic tissue) cannot be excluded. Also, it is possible
that CXCR4
+Lin
–CD45
- cell depletion in the PB may have
resulted from their excessive utilization in the ongoing repair
of continuously damaged tissues. This is an attractive
hypothesis that considers the possibility that CXCR4-
positive cells may attach locally or be recruited distally to
the sites of injury. Interestingly, the general reduction of
CXCR4
+Lin
–CD45
- cells detected in patients with concom-
itant hypertension and atherosclerosis in our study was
accompanied by an enhanced GFAP,β-III-tubulin,andnestin
mRNA expression in these cells. Thus, it may be considered
that disorders of a chronic nature, especially those of a
systemic nature, induce a relatively specific regenerative
response via the release of TCSCs from bone marrow or
other tissue niches into the PB. Hence, it is possible that
circulatingCXCR4
+Lin
–CD45
- cells may exhibit a beneficial
role in the reparative process.
1792 Graefes Arch Clin Exp Ophthalmol (2011) 249:1785–1794Furthermore, this study demonstrated for the first time the
higher expression of β-III-tubulin in the PB cells of patients
with the exudative form of AMD. This may suggest that
circulating cells have a potential ability to regenerate injured
retinal tissue. Moreover, the negative correlation between PB
CXCR4
+Lin
–CD45
- cell concentrations and the intracellular
expression of neuroprogenitor and glial cell markers ob-
served in patients with neovascular AMD may indicate
pathophysiological relationships between the analysed
parameters. The possibility that a relatively small pool of
circulating CXCR4
+Lin
–CD45
- cells, under conditions of
their poor mobilization into the PB, comprise a compara-
tively large percentage of neural and glial progenitor cells
cannot be excluded. However, the exact proportions of
neural and glial TCSCs cells within the population of
CXCR4
+Lin
–CD45
- cells remain to be determined.
The mechanism by which SPCs home into the damaged
retina is not fully understood either. Many reports have
indicated that stem-cell migration and tissue-specific homing
are regulated by chemokines/growth factors and their recep-
tors [24]. Among the chemokines involved in these
processes, SDF-1 plays a unique and very important
biological role by regulating the trafficking of SPCs
expressing the chemokine receptor CXCR4 [25].
In our study, we found a significantly lower SDF-1
plasma level in exudative AMD patients than in the healthy
controls. Furthermore, our findings revealed a negative
correlation between the SDF-1 plasma level and the number
of CXCR4
+Lin
–CD45
- cells in healthy controls, as well as a
similar relationship between SDF-1 concentration and the
expression of β-III-tubulin in PB cells in AMD patients.
These results collectively indicate a possible pathophysio-
logical linkage between the distribution of bone-marrow-
derived neural progenitors in tissues and systemic SDF-1
levels. It should be noted that the current findings are in
accordance with our earlier observations, where we showed
that SDF-1 concentration was significantly lower in the
group of AMD patients than in the healthy controls [26].
However, it was not clarified whether the SDF-1 plasma
level reflects the actual concentration of the chemokine within
the injured retina or not. Therefore, the possibility that a low
SDF-1 plasma level makes the attraction of bone-marrow-
derived neural progenitors into the damaged retina ineffective
cannot be excluded, since they stay in circulation at a higher
concentration.Inlightoftheabove,arecentreportbyBhuttoet
al. focused on the immunolocalisation of SDF-1 and its
receptor in human retina. The most prominent localisation of
SDF–1 was detected in RPE cells and the inner photoreceptor
matrix, while CXCR4 expression was mostly identified in
circulating cells within the lumen of blood vessels. More
interestingly, SDF-1 immunoreactivity was significantly re-
duced in advanced stages of AMD when compared to normal
aged choroidal stroma and RPE [27]. Since these findings are
consistent with our observations, we suggest a disturbed local
synthesis of the chemokine under conditions of chronic
vascular impairment. Our suggestion could be additionally
supported by reports showing that SDF-1 levels are elevated in
acute ischaemia but decreased in chronically ischaemic tissue
[28]. However, it cannot be excluded that other factors may
also play an important role in recruiting circulating SPCs to
sites of retinal injury [6]. Therefore,completeelucidationof all
the mechanisms involved in mutual cellular and humoral
interactions during the course of AMD requires further studies.
Taken together, the results presented here support the
hypothesis of a genuine role of TCSCs in the maintenance of
retinal tissue homeostasis. However, the process of differen-
tiation of circulating TCSCs into mature cells at the place of
injury, as well as the regulatory mechanisms involved in this
process, was not entirely clarified. Further studies are needed
for a precise elucidation of these issues. We conclude that
neural progenitor cells, together with a low SDF-1 concentra-
tion, may play a considerable role in process of AMD
development. Our findings extend current knowledge on the
pathophysiological circulationofSPCsinthe courseofAMD,
and they may have implications for the future development of
effective preventive measures against this disease.
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